Biotechnology Stocks I Performance Guide: Janux Therapeutics, Inc. (JANX)
JANX has no dividends.
Table and Chart of JANX Performance
See what a $1,000 investment in JANX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| JANX Returns | |
|---|---|
| Start Date | Jul-30-2021 |
| Start Price | $32.43 |
| End Date | May-10-2024 |
| End Price | $48.92 |
| # Prices | 35 |
| Min Date | Oct-31-2023 |
| Min Price | $6.42 |
| Max Date | Apr-30-2024 |
| Max Price | $57.00 |
| Total Return | 50.85% |
| Annualized Return | 15.14% |
| Current Value of $1,000 Purchase | $1,508 |
| Number Returns | 595 |
| Average Return | 38.24% |
| Number Profitable Returns | 231 |
| Percent Profitable Returns | 38.82% |
| Number Unprofitable Returns | 364 |
| Percent Unprofitable Returns | 61.18% |
| Profitable to Unprofitable Returns Ratio | 0.63 |
| JANX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,693,125,000 |
| Beta | 3.869 | Price to Sales | 336.50 |
| Earnings per Share | $-1.3200 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 7.9 |
| PRICE DATA | |
| 52 Week High | $65.6 |
| 52 Week Low | $5.65 |
| Analyst Target Price | $61.29 |
| 50-Day Moving Average | $45.49 |
| 200-Day Moving Average | $19.12 |
| FINANCIAL DATA | |
| Revenue per Share | $0.159 |
| Revenue | $7,287,000 |
| Profit Margin | 0% |
| Return on Equity | -11.5% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
JANX Compare Returns with S&P 500
JANX Trendline Chart
JANX Moving Average Chart
JANX Stock Return Map - See Patterns of Gains and Losses
JANX Stock Returns/Purchase Dates